Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzira immunogenicity and safety study in healthy adults and older adults for the 2008/2009 Northern Hemisphere influenza season
2008-005324-93Phase 4Completed
- Sponsor
- CSL Limited
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of omeprazole in influenza (2 arms), sponsored by CSL Limited. Primary endpoints: Immunogenicity by CPMP criteria and Safety of Enzira. Started Oct 2008; status: completed.
02
Drugs
omeprazole
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-005324-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005324-93.